Paladin signed a license and distribution agreement with Duramed Pharmaceuticals, a wholly owned subsidiary of Barr Pharmaceuticals, which granted Paladin the exclusive Canadian license to market Seasonique.
Jonathan Ross Goodman, president and CEO of Paladin, said: “Seasonique is an excellent strategic fit to our strong women’s health franchise. Seasonique complements Seasonale in offering Canadian women an additional, innovative option in birth control. Like Seasonale, Seasonique is a unique extended-cycle birth control pill.”